Article
Host MICA Polymorphism as a Potential Predictive Marker in Response to Chemotherapy for Colorectal Liver Metastases.
Digestive diseases (Basel, Switzerland) - 1 Jan 2018
Nishioka Yujiro, Shindoh Junichi, Inagaki Yoshinori, Gonoi Wataru, Mitsui Jun, Abe Hiroyuki, Yoshioka Ryuji, Yoshida Shuntaro, Fukayama Masashi, Tsuji Shoji, Hashimoto Masaji, Hasegawa Kiyoshi, Kokudo Norihiro
Abstract excerpt
BACKGROUND: Understanding the genetic background of a tumor is important to better stratify patient prognosis and select optimal treatment. For colorectal liver metastases (CLM), however, clinically available biomarkers remain limited. METHODS: After a comprehensive sequencing of 578 cancer-related genes in 10 patients exhibiting very good/poor responses to chemotherapy, the A5.1 variant of the MICA gene was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
